🇺🇸 FDA
Pipeline program

ELECTROLYTES , VIALEBEX 200 g/L, solution pour perfusion

APHP230864

Phase 3 small_molecule active

Quick answer

ELECTROLYTES , VIALEBEX 200 g/L, solution pour perfusion for Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials